WuXi AppTec Co., Ltd. (WUXAY) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Diagnostics & Research Branche. Der Hauptsitz des Unternehmens ist in Shanghai, China. Der aktuelle CEO ist Ge Li.
WUXAY hat IPO-Datum 2021-02-24, 39,414 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $45.02B.
WuXi AppTec Co., Ltd. is a leading contract research, development, and manufacturing organization headquartered in Shanghai that provides integrated services across the drug development lifecycle. The company serves pharmaceutical and biotech clients globally, offering capabilities in small molecule drug discovery and development, cell and gene therapies, preclinical and clinical testing, and manufacturing services. Operating through six specialized business segments—WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and others—the company supports customers from target discovery through commercial production across multiple therapeutic modalities including small molecules, oligonucleotides, peptides, and complex conjugates. Founded in 2000, WuXi AppTec has established a significant presence across China, Asia, the United States, and Europe.
